Zwitterionic targeting nanodrugs prepared from poly(propyleneimine) dendrimers for enhanced anti-tumor therapy

Development of targeting and high drug loading drug delivery system has been gaining great interest. Zwitterionic modification of the terminal amine groups on G2 poly(propyleneimine) (G2 PPI) dendrimers was achieved via the thiol-ene click reaction, followed by the introduction of the anti-cancer drug paclitaxel and targeting peptides c(RGDfC), then the micelles were formed through self-assembly behavior, subsequently doxorubicin was encapsulated internally, finally the targeting drug-loaded micelles PPIMPRC-DOX were synthesized. The PPIMPRC-DOX micelles were irregular spherical with good monodispersity. The average particle size from TEM image was 63.05nm and the hydrodynamic size was 93.1nm, both of which were relatively uniform. The critical micelle concentration was 48.52μg/mL, the total drug loading efficiency was 32.45%. In vitro release experiments revealed that within the mildly acidic environment of tumors, PPIMPRC-DOX micelles exhibited enhanced release efficiency and increased accumulation of DOX. The anti-nonspecific protein adsorption experiment proved that the interaction between the PPIMPRC-DOX micelles and fibrinogen was very weak, and they had good anti-nonspecific protein adsorption ability. The cytotoxicity assessments using the MTT assay on HeLa cells and A549 cells revealed obvious cytotoxic effects of PPIMPRC-DOX micelles on both cells. Hence, the utilization of zwitterionic G2 PPI dendrimers in constructing PPIMPRC-DOX micelles holds promise as a prospective nanodrug delivery system.